ClearPoint Neuro Inc (NASDAQ:CLPT) traded at $18.32 at close of the session on current trade day and made a downward move of -0.33% on its previous day’s price.
Looking at the stock we see that its previous close was $18.38 and the beta (5Y monthly) reads 1.031 with the day’s price range being $18.15 – $18.85. In terms of its 52-week price range, CLPT has a high of $19.22 and a low of $5.11. The company’s stock has gained about 21.20% over that past 30 days.
ClearPoint Neuro Inc has a market cap of $505.27 million and is expected to release its quarterly earnings report in March.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 8.23M, with a low of 7.4M and a high of 9M. The median projection represents growth squeezing down to 20.85% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 31.84M, or 32.90% up from figures reported last year.
On the other hand, looking at the outlook for the CLPT stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy.
Looking further, we note the current price level is 2.74% off its SMA20 and 12.98% from its 50-day simple moving average. The RSI (14) is pointing at 58.83 while the volatility over the past week is 4.76% and jumps to 5.91% over the past one month. The beta value is 1.03, while the average true range (ATR) is currently pointing at 1.00. The average price target for the stock over the next 12 months is $22.5, with the estimates having a low of $15 and a high of $30. These price ends are 18.12% and -63.76% off the current price level respectively, although investors could be excited at the prospect of a -22.82% if the CLPT share price touches on the median price of $22.5.
Coming back to ClearPoint Neuro Inc (NASDAQ:CLPT), we note that the average 3-month trading volume was 217.69K, while that of the preceding 10-day period stands at 0.15 million. Current shares outstanding are 27.59 million.
The insiders hold 13.38% of the company’s shares while institutions hold 27.99%. The data shows that short shares as of 2025-01-31, stood at 0.65 million at a short ratio of 2.77. This represents a 244.00 short interest in shares outstanding on 2025-01-31. Shares short fall in January from the previous month at 0.74 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 19.12% up in year-to-date price movement.
